Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 1.2 to 0.9.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
Financials
Financial year 2025
Pharmacie de Fragnée from Liège, company number BE0425294817, closed financial year 2025 with a result of € 77,330 after tax. For that financial year Pharmacie de Fragnée recorded a gross margin of € 132,360 and equity of € 87,552. Compared with financial year 2024, the result moved from € 39,413 to € 77,330. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 14, 2026.
€ 87,552
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 77,330
▲ 96% vs 2024
Profit after tax over the fiscal year.
€ 33,719
▼ 9% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 77,000 paid out
100 % of the profit went to the shareholders, mostly to PHARMALIA (100 % of the shares). That is where the money ends up.
People and assets in 2025
0.9
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 27,453
▼ 49% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,215
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 130,497
▼ 15% vs 2024
€ 23,710 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 74,377
▼ 15% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,400
▼ 42% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 185,336 | € 186,812 | € 121,466 | € 132,360 | ▲ 9% |
| Profit after taxes | € 92,747 | € 108,610 | € 39,413 | € 77,330 | ▲ 96% |
| Equity | € 86,198 | € 86,809 | € 87,222 | € 87,552 | |
| Total debts | € 417,244 | € 401,476 | € 304,082 | € 293,370 | ▼ 4% |
| Cash | € 96,562 | € 85,920 | € 36,918 | € 33,719 | ▼ 9% |
| Land & buildings | € 198,181 | € 188,663 | € 179,144 | € 169,626 | ▼ 5% |
| Retained profit | € 67,598 | € 68,209 | € 68,622 | € 68,952 | |
| Dividend | € 92,700 | € 108,000 | € 39,000 | € 77,000 | ▲ 97% |
| Bank debt | € 196,429 | € 175,285 | € 153,319 | € 130,497 | ▼ 15% |
| Balance sheet total | € 503,443 | € 488,284 | € 391,304 | € 380,921 | ▼ 3% |
| Employees (FTE) | 1.2 | 1.2 | 1 | 0.9 | ▼ 0.1 |
Key figures of Pharmacie de Fragnée, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharmacie de Fragnée?
What happened at Pharmacie de Fragnée in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 77,330 (▲ 96% vs 2024). filed late Source: NBB ↗
- Management Céline Thomas SRL became a director. NBB
- Pharmalia BV stepped down as director. NBB
- Pharmalia BV became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 92,747 profit in 2022 to € 77,330 profit in 2025.
Paid € 819 in corporate taxes since 2022.
Best year ever: 2023, with € 108,610 profit.
On average € 121,500 of value added per employee in 2024.
A new publication or filing at Pharmacie de Fragnée? We notify you, reason included.
Follow Pharmacie de FragnéeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of PHARMALIA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Pharmacie de FragnéeBehind Pharmacie de Fragnée is Management Céline Thomas SRL. The shares are held by PHARMALIA (100%).
Directors
According to the 2025 annual accounts
Director · represented by Thomas Céline
Also active at: PHARMACIE PIEDBOEUF
since 2026
Director · represented by Faska Najat
since 2010 · until 2025
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Place du Général-Leman 29
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0425.294.817
- VAT number
- BE 0425.294.817
- Registered office
- Place du Général-Leman 29, 4000 Liège
- Names & denominations
- Pharmacie de Fragnée
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 January 1984
- Peppol
- Active · Active since 6 Jan 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers